Reply to Güner et al.-Management of Obstructive Heart Valve Thrombosis: Differences Between Biological and Mechanical Prostheses
- PMID: 33636249
- DOI: 10.1016/j.cjca.2021.02.011
Reply to Güner et al.-Management of Obstructive Heart Valve Thrombosis: Differences Between Biological and Mechanical Prostheses
Comment on
-
Bioprosthetic Valve Thrombosis and Obstruction Secondary to COVID-19.Can J Cardiol. 2021 Jun;37(6):938.e3-938.e6. doi: 10.1016/j.cjca.2020.10.008. Epub 2020 Oct 24. Can J Cardiol. 2021. PMID: 33485934 Free PMC article.
-
Management of Obstructive Prosthetic Heart Valve Thrombosis: Thrombolytic Therapy or Anticoagulation?Can J Cardiol. 2021 Jun;37(6):938.e7. doi: 10.1016/j.cjca.2021.01.026. Epub 2021 Feb 10. Can J Cardiol. 2021. PMID: 33581192 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical